Does time of CCI measurement affect the evaluation of platelet transfusion effectiveness?

ABO-compatible platelet concentrate Japanese guideline for the appropriate use of blood products (revised in 2017) Platelet transfusion refractoriness Single donor apheresis platelets The corrected count increment (CCI)

Journal

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
ISSN: 1473-0502
Titre abrégé: Transfus Apher Sci
Pays: England
ID NLM: 101095653

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 16 09 2020
revised: 05 03 2021
accepted: 13 03 2021
pubmed: 25 3 2021
medline: 16 12 2021
entrez: 24 3 2021
Statut: ppublish

Résumé

The measurement of corrected count increment at 1-h post-transfusion (CCI-1 h) of platelet concentrate (PC) transfusion is recommended, but in the revised Japanese Guideline (2017) it was changed to "after 10-min to 1-h", following the revision of the guidelines from Western countries. Here, we aimed to investigate on the feasibility to apply the CCI measured at 10-min or 30-min post-transfusion as the surrogate of CCI-1 h. Peripheral blood was collected at 10-min, 30-min and 1-h post-transfusion of PC and the effectiveness of the transfusion was analyzed based on the CCI. In the period from December 2017 to February 2020, 8 patients, who received multiple PC transfusion (total 208) at our institution, were analyzed. We performed the univariate analyses to examine the relationship between CCI value and the categorical variables, p-value <0.1 was obtained for gender (p = 2.91 × 10

Identifiants

pubmed: 33757699
pii: S1473-0502(21)00089-6
doi: 10.1016/j.transci.2021.103123
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

103123

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Reina Matsui (R)

Department of Laboratory Medicine, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, Japan.

Takeshi Hagino (T)

Department of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, Japan. Electronic address: takeshi_hagino2@tokyo-hmt.jp.

Nelson Hirokazu Tsuno (NH)

Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan.

Hideo Ohtani (H)

Department of Laboratory Medicine, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, Japan.

Fumihiro Azuma (F)

Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan.

Mika Matsuhashi (M)

Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan.

Makoto Saito (M)

Clinical Research Support Center, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.

Maya Kobayashi (M)

Department of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, Japan.

Reina Saga (R)

Department of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, Japan.

Hiroko Hidai (H)

Department of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, Japan.

Hisashi Tsutsumi (H)

Department of Laboratory Medicine, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, Japan.

Hideki Akiyama (H)

Department of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, Japan.

Sayuri Motomura (S)

Department of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH